IMDS nasdaq bulletin board Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : IMDS nasdaq bulletin board

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Rayja who wrote (3865)	11/16/1999 3:01:00 PM
From: Rayja	Read Replies (1) of 4122

Imaging Diagnostic Systems Announces Commencement of Clinical Trials at the University of Virginia Medical Center PR Newswire - November 16, 1999 09:42 FORT LAUDERDALE, Fla., Nov. 16 /PRNewswire/ -- Imaging Diagnostic Systems, Inc. (OTC Bulletin Board: IMDS), announced today that the Company has entered into an agreement with the University of Virginia Medical Center in Charlottesville, Virginia as the second approved testing site. The FDA has approved the expansion of this study to gather the additional studies required for the FDA approved protocol. The placement and installation of the Company's CTLM(TM) device for the investigational clinical studies was concluded last week and the patient scanning commenced Monday, November 15, 1999. These comparative studies will consist of a series of patients with specific abnormalities that will compare the CTLM(TM) results to the current methods of breast imaging such as Mammography, Ultrasound and MRI. The commencement of this study is just another significant advancement in the evolution of the Company's CTLM(TM) device and its further development towards the FDA approval process. Imaging Diagnostic Systems has developed the world's first patented laser-based breast mammography system that utilizes state of the art laser technology and proprietary computed algorithms that create contiguous cross sectional slice images of the breast. The examination requires no breast compression or x-rays. This release may contain forward-looking statements with the meanings of section 27A of the Securities act of 1993 and section 21E of the Securities Exchange Act of 1934. Actual results and events could differ materially from those projected as a result of the "known uncertainties" set forth in detail in the Company's filings with the Securities and Exchange Commission. SOURCE Imaging Diagnostic Systems, Inc. /CONTACT: Deborah O'Brien of Imaging Diagnostic Systems, Inc., 954-581-9800/

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next